GSK, UK biggest drug maker, pulls plug on Nigeria deal

Filed under: Company News |

Finally, UK-based GlaxoSmithKline (GSK) Plc has abandoned its plans of increasing its stake in GSK Consumer Nigeria plc. following public outcry by minority shareholders, which led to regulatory intervention. Many market watchers believe that the decision to drop this plan, signposts Britain’s biggest drug maker’s unwillingness to adhere to the Nigerian capital market regulatory instructions…

This content is for Bronze, Silver and Gold members only.
Log In Register